Filter
666
Filtered Results: 666
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
62
New Publications
203
Language
Document type
No document type
346
Studies & Reports
120
Guidelines
96
Manuals
40
Strategic & Response Plan
40
Training Material
9
Fact sheets
9
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
35
Global
34
Kenya
31
Ethiopia
27
Uganda
16
South Africa
14
Western and Central Europe
13
Nepal
11
Tanzania
11
Liberia
11
Sierra Leone
10
Nigeria
10
Philippines
10
Namibia
9
Zambia
9
Ghana
8
Rwanda
8
Ukraine
7
Africa
7
Bangladesh
7
Myanmar / Burma
7
Zimbabwe
6
Indonesia
6
Syria
5
South Sudan
5
Lesotho
4
Malawi
4
Cambodia
4
Congo, Democratic Republic of
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Cameroon
3
Senegal
3
West and Central Africa
3
South–East Asia Region
3
Eswatini/ Swaziland
3
Thailand
2
Fiji
2
Laos
2
Burkina Faso
2
Mozambique
2
Asia
2
Latin America and the Carribbean
2
Jordan
2
East and Southern Africa
2
Vietnam
2
Botswana
2
Pakistan
2
Timor Leste/ East Timor
1
Australia
1
Benin
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Guinea
1
USA
1
Haiti
1
Lithuania
1
Middle East and North Africa
1
Belgium
1
United Kingdom
1
Southern Africa
1
Lebanon
1
Brazil
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
277
Clinical Guidelines
38
Key Resources
35
Public Health
32
Women & Child Health
21
Capacity Building
9
Pharmacy & Technologies
9
Toolboxes
Pharmacy
65
AMR
59
COVID-19
32
Mental Health
29
HIV
29
Planetary Health
28
TB
27
NTDs
25
Rapid Response
18
NCDs
17
Conflict
13
Caregiver
11
Health Financing Toolbox
11
Ebola
9
Global Health Education
9
Specific Hazards
6
Disability
5
Refugee
3
Natural Hazards
3
Social Ethics
2
Health Financing
2
South Sudan
1
Zika
1
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
The objectives of this guidance document are to:
1. Strengthen the capacity of country teams to effectively scale up and manage programmes to address severe acute malnutrition
2. Extend the geographic reach of quality treatment for SAM to all vulnerable communities in need
3. Maximize...
1. Strengthen the capacity of country teams to effectively scale up and manage programmes to address severe acute malnutrition
2. Extend the geographic reach of quality treatment for SAM to all vulnerable communities in need
3. Maximize...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
Waste Management & Research 39(1) DOI: 10.1177/0734242X211029175
Sci Rep. 2016; 6: 25920. Published online 2016 May 16. doi: 10.1038/srep25920
MOH Policy and Guidelines for Health Institutions
This document introduces four strategic objectives and twelve operational principles for good pharmaceutical procurement. These objectives and principles have been developed and endorsed by the Interagency Pharmaceutical Coordination Group (IPC), involving the pharmaceutical advisers of the United ...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
